Clinical trial
Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early…
NCT00247650 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00247650 |
|---|---|
| Title | Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy |
| Official title | Randomized Multi-Center Study Comparing Prolonged Primary Systemic Endocrine Therapy With Letrozole Alone or in Combination With Zoledronic Acid in Early Breast Cancer (NEOadjuvant Study in CANada) |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Zoledronic Acid, Letrozole |
| Enrollment | 190 |
| Start date | Sep 1, 2005 |
| Primary completion | Mar 1, 2007 |
| First posted | Nov 2, 2005 |
| Last update posted | Mar 1, 2017 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: